Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Zero Based Budgeting For Freelancers helps convert fluctuating earnings into predictable spending, building a solid financial foundation.
15,597 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Markets are rotating away from AI hype toward real, tangible assets. A small engineering firm is asserting itself wit...
Legend Awakes closes a weeks-long mystery teaser with a cinematic reveal, introducing Alberich Token and a narrative-...
A senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
Verizon stock has trended flat lately, but July 24 earnings could spark movement. This guide breaks down whether shou...
Crypto.com cuts around staff by about 12%, eliminating roughly 180 roles as it refocuses on AI-enabled enterprise ser...
As 2026 unfolds, investors face a choice between StubHub's fast-growing digital ticketing platform and Build-A-Bear's...
Fresh data on unemployment filings show the labor market staying resilient. The big question remains whether the econ...
A famous AI investor argues the economics of AI deployment could shift cash flow toward infrastructure vendors like N...
Three growth-focused ETFs have fallen this month as rates move and leadership shifts unsettle risk assets. One fund s...
In 2026, four Dividend Kings are outperforming the S&P 500 as investors pivot to cash-flow creators. The move signals...
Oil markets surged as geopolitical tensions flared, with brent crude briefly topping the $119 mark. This article outl...